CF
48
3
FRT
53
-3
PHM
59
7
NEE
57
-18
MLM
63
2
RL
76
-2
ES
45
5
LH
48
-4
TAP
29
-5
PRGO
29
-2
DOW
38
-4
ESS
39
-5
MA
43
-3
HST
42
-3
GLW
65
4
ZION
63
2
TDC
80
-3
HIG
52
-4
PLD
48
-3
DUK
55
-2
CF
48
3
FRT
53
-3
PHM
59
7
NEE
57
-18
MLM
63
2
RL
76
-2
ES
45
5
LH
48
-4
TAP
29
-5
PRGO
29
-2
DOW
38
-4
ESS
39
-5
MA
43
-3
HST
42
-3
GLW
65
4
ZION
63
2
TDC
80
-3
HIG
52
-4
PLD
48
-3
DUK
55
-2
Financhill
Back

Olema Pharmaceuticals, Inc. 10K Form

Buy
63

OLMA
Olema Pharmaceuticals, Inc.

Last Price:
$27.66
Seasonality Move:
-18.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OLMA News And Ratings

See the #1 stock for the next 7 days that we like better than OLMA

OLMA Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-34.5M
Price / Cash Flow: 0
Annual Sales: $4.48
Price / Book: 6.17

Profitability

EPS (TTM): -1.81190
Net Income (TTM): $-150M
Gross Margin: $-393K
Return on Equity: -45.61%
Return on Assets: -38.84%

Olema Pharmaceuticals, Inc. Earnings Forecast

Key Olema Pharmaceuticals, Inc. Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 1 years.

Olema Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: OLMA
CUSIP: 68062P
Website: olema.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 8.03
Quick Ratio: 7.9

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OLMA Technical Analysis vs Fundamental Analysis

Buy
63
Olema Pharmaceuticals, Inc. (OLMA) is a Buy

Is Olema Pharmaceuticals, Inc. a Buy or a Sell?